The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis

NCT03340649

Sepsis

UNKNOWN

Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis

NCT03952390

Sepsis

COMPLETED

The Early Coagulopathy for the Prognosis in Sepsis

NCT04582188

Sepsis Coagulopathy Outcome, Fatal

UNKNOWN

Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock

NCT04948372

Septic Shock

COMPLETED NA

Comparison the Value of Several Biomarkers of Sepsis

NCT01388725

Systemic Inflammatory Response Syndrome Sepsis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

90 patients will be included in this study. Blood samples from these patients in the first day, the third day, were maintained and tested to detect the change of rTEM level. Severity of illness and survival status of every patient were recorded within 28 days. The objective is to observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survivors

Sepsis induced ARDS patients who survived

Taking peripheral blood

Intervention Type OTHER

Taking peripheral blood of no more than 3ml

Nonsurvivors

Sepsis induced ARDS patients who not survived

Taking peripheral blood

Intervention Type OTHER

Taking peripheral blood of no more than 3ml

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Taking peripheral blood

Taking peripheral blood of no more than 3ml

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Diagnosed as Sepsis 3.0 Patients signing informed consent

Exclusion Criteria

Pregnant women Patients with tumor、hepatitis、liver cirrhosis、acute myocardial infarction、chronic renal tubular nephritis、interstitial pneumonia、acute pancreatitis、systemic lupus erythenatosus、ulcerative colitis、crohn's disease、HELLP syndrome

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes